Log in

NYSE:RAD - Rite Aid Stock Price, Forecast & News

$14.62
+0.40 (+2.81 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$14.02
Now: $14.62
$14.78
50-Day Range
$11.66
MA: $13.44
$20.30
52-Week Range
$5.04
Now: $14.62
$23.88
Volume4.23 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryDrug Retail
SectorN/A
CUSIP76775410
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees51,000
Next Earnings Date4/9/2020 (Estimated)
OptionableOptionable

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.


Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Rite Aid shares reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) released its quarterly earnings data on Thursday, December, 19th. The company reported $0.54 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.09 by $0.45. The firm had revenue of $5.46 billion for the quarter, compared to analyst estimates of $5.42 billion. Rite Aid's quarterly revenue was up .2% on a year-over-year basis. During the same period in the prior year, the company posted $0.01 earnings per share. View Rite Aid's Earnings History.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release their next quarterly earnings announcement on Thursday, April 9th 2020. View Earnings Estimates for Rite Aid.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid issued an update on its FY20 earnings guidance on Thursday, December, 19th. The company provided earnings per share guidance of $0.13-0.55 for the period, compared to the Thomson Reuters consensus estimate of $0.18. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $21.64 billion.

What price target have analysts set for RAD?

3 brokerages have issued 12-month price targets for Rite Aid's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate Rite Aid's share price to reach $12.00 in the next year. This suggests that the stock has a possible downside of 17.9%. View Analyst Price Targets for Rite Aid.

What is the consensus analysts' recommendation for Rite Aid?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 sell ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rite Aid.

Has Rite Aid been receiving favorable news coverage?

Media coverage about RAD stock has been trending somewhat positive this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Rite Aid earned a news sentiment score of 2.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 17,850,000 shares, an increase of 23.3% from the January 15th total of 14,480,000 shares. Based on an average daily trading volume, of 6,500,000 shares, the days-to-cover ratio is presently 2.7 days. Currently, 33.9% of the shares of the stock are short sold. View Rite Aid's Current Options Chain.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (CLF), Advanced Micro Devices (AMD), General Electric (GE), Lantronix (LTRX) and AK Steel (AKS).

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:
  • Mr. John T. Standley, CEO & Director (Age 56)
  • Mr. Kermit Ray Crawford, Pres & COO (Age 60)
  • Mr. Bryan B. Everett, Chief Operating Officer (Age 46)
  • Mr. Darren Wayne Karst, Exec. Officer (Age 59)
  • Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy & Retail Operations (Age 49)

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (2.95%), Charles Schwab Investment Management Inc. (1.54%), Creative Planning (1.01%), Bank of New York Mellon Corp (0.56%), UBS Asset Management Americas Inc. (0.23%) and California Public Employees Retirement System (0.19%). View Institutional Ownership Trends for Rite Aid.

Which major investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including Creative Planning, State Street Corp, Cubist Systematic Strategies LLC, UBS Asset Management Americas Inc., Stifel Financial Corp, New York State Common Retirement Fund, Investors Asset Management of Georgia Inc. GA ADV and NEXT Financial Group Inc. View Insider Buying and Selling for Rite Aid.

Which major investors are buying Rite Aid stock?

RAD stock was bought by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., SG Americas Securities LLC, UBS Group AG, Bainco International Investors, Bank of New York Mellon Corp, Russell Investments Group Ltd., Bank of America Corp DE and California Public Employees Retirement System. View Insider Buying and Selling for Rite Aid.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $14.62.


MarketBeat Community Rating for Rite Aid (NYSE RAD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  749 (Vote Outperform)
Underperform Votes:  750 (Vote Underperform)
Total Votes:  1,499
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel